Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Hepatocellular | 39 | 2024 | 2327 | 6.100 |
Why?
|
Liver Neoplasms | 43 | 2024 | 4352 | 5.410 |
Why?
|
Liver Cirrhosis | 39 | 2024 | 1961 | 4.640 |
Why?
|
Hepatitis C, Chronic | 10 | 2020 | 1032 | 2.360 |
Why?
|
Aspirin | 11 | 2024 | 3135 | 2.340 |
Why?
|
Fatty Liver | 3 | 2024 | 810 | 1.700 |
Why?
|
Liver | 16 | 2024 | 7559 | 1.500 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 8 | 2023 | 3249 | 1.100 |
Why?
|
Hepatitis B, Chronic | 2 | 2020 | 413 | 0.980 |
Why?
|
Liver Diseases | 3 | 2024 | 1304 | 0.930 |
Why?
|
GTP-Binding Proteins | 2 | 2019 | 945 | 0.920 |
Why?
|
Antiviral Agents | 8 | 2025 | 3068 | 0.910 |
Why?
|
Sweden | 10 | 2022 | 1381 | 0.890 |
Why?
|
End Stage Liver Disease | 3 | 2024 | 369 | 0.880 |
Why?
|
Cardiovascular Diseases | 14 | 2022 | 15647 | 0.870 |
Why?
|
Gastrointestinal Hemorrhage | 3 | 2021 | 1127 | 0.810 |
Why?
|
Adiposity | 4 | 2021 | 1892 | 0.750 |
Why?
|
Risk Factors | 51 | 2025 | 74857 | 0.730 |
Why?
|
Somatotypes | 1 | 2020 | 39 | 0.710 |
Why?
|
Atrial Fibrillation | 3 | 2024 | 5185 | 0.710 |
Why?
|
Hepatorenal Syndrome | 1 | 2021 | 76 | 0.700 |
Why?
|
Hepatic Encephalopathy | 1 | 2021 | 143 | 0.690 |
Why?
|
Anticholesteremic Agents | 2 | 2018 | 970 | 0.680 |
Why?
|
Risk Reduction Behavior | 4 | 2020 | 1121 | 0.670 |
Why?
|
Biliary Tract Neoplasms | 4 | 2023 | 186 | 0.650 |
Why?
|
Coronary Artery Disease | 5 | 2022 | 6544 | 0.640 |
Why?
|
Esophageal and Gastric Varices | 1 | 2021 | 215 | 0.630 |
Why?
|
Peritonitis | 1 | 2021 | 368 | 0.630 |
Why?
|
Biopsy | 13 | 2024 | 6768 | 0.630 |
Why?
|
Pyridones | 1 | 2024 | 817 | 0.620 |
Why?
|
Warfarin | 2 | 2024 | 1494 | 0.620 |
Why?
|
Eicosanoids | 1 | 2020 | 284 | 0.610 |
Why?
|
Dyslipidemias | 2 | 2016 | 871 | 0.610 |
Why?
|
Diabetes Mellitus, Type 2 | 9 | 2023 | 12235 | 0.600 |
Why?
|
Coffee | 3 | 2023 | 593 | 0.600 |
Why?
|
Proportional Hazards Models | 17 | 2022 | 12529 | 0.580 |
Why?
|
Cohort Studies | 27 | 2024 | 41684 | 0.580 |
Why?
|
Metabolic Diseases | 1 | 2023 | 686 | 0.550 |
Why?
|
Simvastatin | 1 | 2019 | 345 | 0.550 |
Why?
|
Dipeptidyl-Peptidase IV Inhibitors | 1 | 2021 | 317 | 0.550 |
Why?
|
Intra-Abdominal Fat | 3 | 2021 | 624 | 0.550 |
Why?
|
Obesity | 12 | 2023 | 13085 | 0.530 |
Why?
|
Humans | 114 | 2025 | 766117 | 0.530 |
Why?
|
Middle Aged | 65 | 2024 | 223083 | 0.510 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2020 | 2271 | 0.510 |
Why?
|
Hepatitis, Autoimmune | 3 | 2023 | 173 | 0.500 |
Why?
|
Fluorenes | 2 | 2017 | 160 | 0.490 |
Why?
|
Heart Arrest | 2 | 2023 | 1516 | 0.490 |
Why?
|
Uridine Monophosphate | 1 | 2015 | 67 | 0.490 |
Why?
|
Follow-Up Studies | 24 | 2024 | 39243 | 0.480 |
Why?
|
Incidence | 17 | 2023 | 21513 | 0.480 |
Why?
|
Natural Language Processing | 1 | 2024 | 1198 | 0.480 |
Why?
|
Thrombocytopenia | 1 | 2023 | 1172 | 0.470 |
Why?
|
Adult | 52 | 2024 | 223139 | 0.470 |
Why?
|
Prospective Studies | 30 | 2024 | 54812 | 0.470 |
Why?
|
Anti-Inflammatory Agents | 1 | 2024 | 1805 | 0.460 |
Why?
|
Fibrosis | 5 | 2023 | 2073 | 0.450 |
Why?
|
Hepacivirus | 3 | 2015 | 1343 | 0.440 |
Why?
|
Clostridium perfringens | 1 | 2013 | 29 | 0.440 |
Why?
|
Pyrazoles | 1 | 2024 | 2031 | 0.440 |
Why?
|
Female | 74 | 2024 | 396233 | 0.440 |
Why?
|
Weight Gain | 2 | 2021 | 2356 | 0.440 |
Why?
|
Heart Failure | 4 | 2022 | 11837 | 0.430 |
Why?
|
Primary Prevention | 1 | 2020 | 1187 | 0.410 |
Why?
|
Hypoglycemic Agents | 3 | 2023 | 3107 | 0.410 |
Why?
|
Male | 66 | 2024 | 363935 | 0.410 |
Why?
|
Aged | 42 | 2024 | 171219 | 0.400 |
Why?
|
Stroke | 4 | 2024 | 9748 | 0.390 |
Why?
|
Hemorrhage | 1 | 2024 | 3466 | 0.390 |
Why?
|
Secondary Prevention | 1 | 2018 | 1470 | 0.380 |
Why?
|
Anticoagulants | 2 | 2024 | 4857 | 0.380 |
Why?
|
Hemolysis | 1 | 2013 | 408 | 0.370 |
Why?
|
Benzimidazoles | 2 | 2017 | 862 | 0.370 |
Why?
|
Myocardial Ischemia | 1 | 2021 | 2132 | 0.360 |
Why?
|
Diet | 7 | 2023 | 8087 | 0.360 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2020 | 2768 | 0.350 |
Why?
|
Resuscitation | 1 | 2015 | 681 | 0.350 |
Why?
|
Kidney Failure, Chronic | 1 | 2023 | 2504 | 0.340 |
Why?
|
Mortality | 1 | 2021 | 2911 | 0.340 |
Why?
|
Ventricular Remodeling | 1 | 2017 | 1276 | 0.330 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2023 | 2306 | 0.310 |
Why?
|
Hepatitis C | 2 | 2015 | 1596 | 0.300 |
Why?
|
Blood Transfusion | 1 | 2015 | 1307 | 0.300 |
Why?
|
Catheterization | 1 | 2013 | 1426 | 0.300 |
Why?
|
Interleukin-6 | 1 | 2018 | 3227 | 0.300 |
Why?
|
Drug Costs | 1 | 2015 | 1195 | 0.280 |
Why?
|
Propensity Score | 4 | 2024 | 1973 | 0.270 |
Why?
|
Insulin Resistance | 2 | 2021 | 3988 | 0.270 |
Why?
|
Risk Assessment | 12 | 2025 | 24276 | 0.270 |
Why?
|
Body Mass Index | 9 | 2021 | 13046 | 0.270 |
Why?
|
Aspartate Aminotransferases | 2 | 2019 | 416 | 0.270 |
Why?
|
Clostridium Infections | 1 | 2013 | 563 | 0.270 |
Why?
|
Bacteremia | 1 | 2013 | 988 | 0.260 |
Why?
|
Cross Infection | 1 | 2015 | 1427 | 0.260 |
Why?
|
Bile Duct Neoplasms | 3 | 2023 | 624 | 0.260 |
Why?
|
Nurses | 3 | 2021 | 2503 | 0.260 |
Why?
|
Crohn Disease | 1 | 2018 | 2281 | 0.250 |
Why?
|
Registries | 6 | 2022 | 8347 | 0.240 |
Why?
|
Disease Progression | 7 | 2023 | 13616 | 0.240 |
Why?
|
Lipid Metabolism | 3 | 2024 | 1893 | 0.230 |
Why?
|
Cholangiocarcinoma | 2 | 2020 | 577 | 0.230 |
Why?
|
Heart | 1 | 2017 | 4419 | 0.230 |
Why?
|
Exercise | 2 | 2023 | 5939 | 0.220 |
Why?
|
United States | 19 | 2024 | 72920 | 0.220 |
Why?
|
Severity of Illness Index | 8 | 2022 | 15882 | 0.210 |
Why?
|
Virus Activation | 1 | 2025 | 322 | 0.210 |
Why?
|
Hepatitis, Viral, Human | 1 | 2023 | 141 | 0.200 |
Why?
|
Comorbidity | 6 | 2021 | 10579 | 0.200 |
Why?
|
Gallbladder Neoplasms | 2 | 2023 | 190 | 0.200 |
Why?
|
Tea | 1 | 2023 | 289 | 0.200 |
Why?
|
Death Certificates | 1 | 2023 | 172 | 0.190 |
Why?
|
Bradycardia | 1 | 2023 | 304 | 0.190 |
Why?
|
Ascites | 2 | 2021 | 336 | 0.190 |
Why?
|
Biliary Tract | 1 | 2022 | 137 | 0.190 |
Why?
|
Life Style | 3 | 2022 | 3928 | 0.190 |
Why?
|
Hepatitis B virus | 1 | 2025 | 532 | 0.180 |
Why?
|
Colitis, Lymphocytic | 1 | 2021 | 23 | 0.180 |
Why?
|
Colitis, Collagenous | 1 | 2021 | 25 | 0.180 |
Why?
|
Feeding Behavior | 3 | 2022 | 3209 | 0.180 |
Why?
|
Anti-Bacterial Agents | 3 | 2023 | 7474 | 0.180 |
Why?
|
Embolism | 1 | 2024 | 401 | 0.180 |
Why?
|
Laxatives | 1 | 2021 | 94 | 0.180 |
Why?
|
Prevalence | 5 | 2021 | 15827 | 0.180 |
Why?
|
Sports Medicine | 1 | 2023 | 239 | 0.170 |
Why?
|
Nuts | 2 | 2019 | 265 | 0.170 |
Why?
|
Case-Control Studies | 10 | 2024 | 22228 | 0.170 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2021 | 16040 | 0.170 |
Why?
|
Clinical Coding | 1 | 2021 | 187 | 0.170 |
Why?
|
Gallstones | 1 | 2022 | 285 | 0.160 |
Why?
|
Double-Blind Method | 3 | 2024 | 12426 | 0.160 |
Why?
|
Sulfonylurea Compounds | 1 | 2021 | 220 | 0.160 |
Why?
|
Gastrointestinal Motility | 1 | 2021 | 235 | 0.160 |
Why?
|
Hepatitis B | 1 | 2025 | 709 | 0.160 |
Why?
|
Waist Circumference | 2 | 2020 | 934 | 0.160 |
Why?
|
Young Adult | 9 | 2024 | 59868 | 0.160 |
Why?
|
Diet, Vegetarian | 1 | 2021 | 181 | 0.160 |
Why?
|
Alcohol Drinking | 3 | 2020 | 4044 | 0.160 |
Why?
|
Catheter Ablation | 1 | 2012 | 2787 | 0.160 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2020 | 187 | 0.160 |
Why?
|
Liver Diseases, Alcoholic | 1 | 2021 | 157 | 0.160 |
Why?
|
Massachusetts | 3 | 2021 | 8882 | 0.150 |
Why?
|
Multivariate Analysis | 4 | 2019 | 12061 | 0.150 |
Why?
|
Dietary Fiber | 2 | 2019 | 767 | 0.150 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 390 | 0.150 |
Why?
|
Inflammation | 4 | 2024 | 10860 | 0.150 |
Why?
|
Logistic Models | 4 | 2024 | 13273 | 0.150 |
Why?
|
International Classification of Diseases | 1 | 2024 | 934 | 0.150 |
Why?
|
Thinness | 1 | 2021 | 482 | 0.150 |
Why?
|
Diet, Carbohydrate-Restricted | 1 | 2021 | 263 | 0.150 |
Why?
|
Thiazolidinediones | 1 | 2021 | 460 | 0.150 |
Why?
|
Hyperinsulinism | 1 | 2021 | 402 | 0.150 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2020 | 557 | 0.150 |
Why?
|
Diet Surveys | 1 | 2021 | 1159 | 0.140 |
Why?
|
Obesity, Abdominal | 2 | 2021 | 371 | 0.140 |
Why?
|
Human Growth Hormone | 1 | 2022 | 639 | 0.140 |
Why?
|
Prognosis | 8 | 2021 | 29912 | 0.140 |
Why?
|
Age of Onset | 2 | 2021 | 3344 | 0.140 |
Why?
|
Adolescent | 9 | 2024 | 88819 | 0.140 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2019 | 10737 | 0.140 |
Why?
|
Aged, 80 and over | 7 | 2021 | 59515 | 0.140 |
Why?
|
Retrospective Studies | 10 | 2023 | 81565 | 0.140 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2020 | 1527 | 0.130 |
Why?
|
Overweight | 3 | 2023 | 2444 | 0.130 |
Why?
|
Platelet Count | 1 | 2019 | 784 | 0.130 |
Why?
|
Gonadal Steroid Hormones | 1 | 2020 | 706 | 0.130 |
Why?
|
Cross-Sectional Studies | 7 | 2023 | 26290 | 0.130 |
Why?
|
Hormones | 1 | 2020 | 865 | 0.130 |
Why?
|
Hyperammonemia | 1 | 2017 | 80 | 0.130 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2021 | 2431 | 0.130 |
Why?
|
Dairy Products | 1 | 2019 | 490 | 0.130 |
Why?
|
Reproduction | 1 | 2020 | 645 | 0.120 |
Why?
|
Benzamides | 1 | 2021 | 1376 | 0.120 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2016 | 190 | 0.120 |
Why?
|
Consensus | 2 | 2024 | 3202 | 0.120 |
Why?
|
Diastole | 1 | 2017 | 785 | 0.120 |
Why?
|
Administration, Oral | 1 | 2023 | 4016 | 0.120 |
Why?
|
Alanine Transaminase | 1 | 2017 | 608 | 0.120 |
Why?
|
Diabetes Complications | 1 | 2021 | 1318 | 0.120 |
Why?
|
Paracentesis | 1 | 2015 | 99 | 0.120 |
Why?
|
Anthropometry | 1 | 2019 | 1339 | 0.110 |
Why?
|
Tandem Mass Spectrometry | 1 | 2020 | 1194 | 0.110 |
Why?
|
Glutamine | 1 | 2017 | 575 | 0.110 |
Why?
|
Piperacillin | 1 | 2013 | 37 | 0.110 |
Why?
|
Thrombophilia | 1 | 2016 | 308 | 0.110 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 5388 | 0.110 |
Why?
|
Penicillanic Acid | 1 | 2013 | 41 | 0.110 |
Why?
|
Risk | 3 | 2020 | 9599 | 0.110 |
Why?
|
Coma | 1 | 2017 | 485 | 0.110 |
Why?
|
Clindamycin | 1 | 2013 | 138 | 0.110 |
Why?
|
Blood Component Transfusion | 1 | 2013 | 141 | 0.100 |
Why?
|
Genotype | 2 | 2019 | 13028 | 0.100 |
Why?
|
Walking | 1 | 2020 | 1198 | 0.100 |
Why?
|
Internationality | 1 | 2018 | 1007 | 0.100 |
Why?
|
Algorithms | 2 | 2024 | 14066 | 0.100 |
Why?
|
Albumins | 1 | 2015 | 578 | 0.100 |
Why?
|
Rhode Island | 1 | 2012 | 351 | 0.100 |
Why?
|
Creatinine | 1 | 2017 | 1916 | 0.090 |
Why?
|
Osteoporosis | 1 | 2021 | 1582 | 0.090 |
Why?
|
Postmenopause | 1 | 2020 | 2517 | 0.090 |
Why?
|
Atherosclerosis | 2 | 2017 | 3418 | 0.090 |
Why?
|
Proteomics | 1 | 2024 | 3907 | 0.090 |
Why?
|
Body Weight | 1 | 2021 | 4626 | 0.090 |
Why?
|
Vancomycin | 1 | 2013 | 504 | 0.090 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 14645 | 0.080 |
Why?
|
Premature Birth | 1 | 2021 | 1830 | 0.080 |
Why?
|
Lipids | 2 | 2022 | 3316 | 0.080 |
Why?
|
Cause of Death | 1 | 2019 | 3715 | 0.080 |
Why?
|
Survival Rate | 4 | 2020 | 12827 | 0.080 |
Why?
|
Fatal Outcome | 1 | 2013 | 1836 | 0.080 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2015 | 889 | 0.080 |
Why?
|
Bile Ducts, Intrahepatic | 2 | 2020 | 307 | 0.080 |
Why?
|
Indoles | 1 | 2016 | 1833 | 0.070 |
Why?
|
Alleles | 1 | 2019 | 6892 | 0.070 |
Why?
|
Pregnancy Complications | 1 | 2021 | 2970 | 0.070 |
Why?
|
Lung Neoplasms | 1 | 2012 | 13483 | 0.070 |
Why?
|
Regression Analysis | 1 | 2017 | 6324 | 0.070 |
Why?
|
DNA, Viral | 1 | 2014 | 2200 | 0.070 |
Why?
|
Artificial Intelligence | 1 | 2022 | 2662 | 0.070 |
Why?
|
Virus Replication | 1 | 2015 | 2458 | 0.070 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4853 | 0.070 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2017 | 3678 | 0.070 |
Why?
|
Pediatrics | 1 | 2021 | 3609 | 0.060 |
Why?
|
Disease Outbreaks | 1 | 2015 | 1761 | 0.060 |
Why?
|
Biomedical Research | 1 | 2021 | 3458 | 0.060 |
Why?
|
Genetic Variation | 1 | 2020 | 6612 | 0.060 |
Why?
|
Chronic Disease | 1 | 2020 | 9354 | 0.060 |
Why?
|
Child | 3 | 2022 | 80573 | 0.060 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2023 | 1935 | 0.060 |
Why?
|
Survival Analysis | 2 | 2021 | 10087 | 0.060 |
Why?
|
Longitudinal Studies | 2 | 2019 | 14747 | 0.060 |
Why?
|
Respiratory Insufficiency | 1 | 2013 | 1241 | 0.060 |
Why?
|
Echocardiography | 1 | 2017 | 5041 | 0.060 |
Why?
|
Ventricular Function, Left | 1 | 2017 | 3930 | 0.060 |
Why?
|
Endothelium, Vascular | 1 | 2016 | 4423 | 0.060 |
Why?
|
Acute Disease | 1 | 2015 | 7237 | 0.060 |
Why?
|
Pancreatic Neoplasms | 1 | 2022 | 5454 | 0.060 |
Why?
|
Vegetables | 2 | 2020 | 1200 | 0.060 |
Why?
|
Electronic Health Records | 1 | 2021 | 4863 | 0.050 |
Why?
|
Neoplasms | 2 | 2023 | 22344 | 0.050 |
Why?
|
Wounds and Injuries | 1 | 2016 | 2513 | 0.050 |
Why?
|
Smoking | 1 | 2019 | 9082 | 0.050 |
Why?
|
Pilot Projects | 1 | 2015 | 8724 | 0.050 |
Why?
|
Health Care Costs | 1 | 2015 | 3243 | 0.050 |
Why?
|
Confidence Intervals | 2 | 2019 | 2915 | 0.050 |
Why?
|
Sex Factors | 3 | 2020 | 10614 | 0.050 |
Why?
|
Dietary Fats | 2 | 2020 | 2003 | 0.050 |
Why?
|
Blood Pressure | 1 | 2017 | 8532 | 0.050 |
Why?
|
Growth Hormone | 1 | 2023 | 567 | 0.050 |
Why?
|
Fluoroquinolones | 1 | 2023 | 307 | 0.050 |
Why?
|
Practice Guidelines as Topic | 2 | 2015 | 7424 | 0.050 |
Why?
|
Treatment Outcome | 4 | 2017 | 65219 | 0.040 |
Why?
|
Time Factors | 3 | 2020 | 40108 | 0.040 |
Why?
|
Clinical Pharmacy Information Systems | 1 | 2020 | 102 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 2 | 2020 | 18076 | 0.040 |
Why?
|
Chemoprevention | 1 | 2022 | 327 | 0.040 |
Why?
|
Poultry | 1 | 2019 | 79 | 0.040 |
Why?
|
Bile Ducts, Extrahepatic | 1 | 2019 | 50 | 0.040 |
Why?
|
Delphi Technique | 1 | 2024 | 893 | 0.040 |
Why?
|
Coronary Angiography | 2 | 2022 | 4498 | 0.040 |
Why?
|
Meat Products | 1 | 2019 | 97 | 0.040 |
Why?
|
Estrogen Receptor beta | 1 | 2020 | 171 | 0.040 |
Why?
|
Common Bile Duct Neoplasms | 1 | 2019 | 121 | 0.040 |
Why?
|
Ampulla of Vater | 1 | 2019 | 150 | 0.040 |
Why?
|
Autopsy | 1 | 2023 | 1011 | 0.040 |
Why?
|
Republic of Korea | 1 | 2021 | 591 | 0.040 |
Why?
|
Bile Ducts | 1 | 2020 | 288 | 0.040 |
Why?
|
Trans Fatty Acids | 1 | 2019 | 155 | 0.040 |
Why?
|
Waist-Hip Ratio | 1 | 2019 | 521 | 0.040 |
Why?
|
Dietary Fats, Unsaturated | 1 | 2019 | 223 | 0.040 |
Why?
|
Gastroenterology | 1 | 2025 | 593 | 0.040 |
Why?
|
2-Naphthylamine | 1 | 2017 | 20 | 0.040 |
Why?
|
Reference Standards | 1 | 2021 | 1011 | 0.040 |
Why?
|
Macrocyclic Compounds | 1 | 2017 | 68 | 0.040 |
Why?
|
Sodium Benzoate | 1 | 2017 | 14 | 0.040 |
Why?
|
Glycemic Index | 1 | 2019 | 400 | 0.030 |
Why?
|
Phenylacetates | 1 | 2017 | 112 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2024 | 3801 | 0.030 |
Why?
|
Medicare | 1 | 2015 | 6820 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2024 | 36548 | 0.030 |
Why?
|
Fishes | 1 | 2019 | 607 | 0.030 |
Why?
|
Drug Therapy, Combination | 2 | 2017 | 6309 | 0.030 |
Why?
|
Siblings | 1 | 2020 | 828 | 0.030 |
Why?
|
Uracil | 1 | 2017 | 210 | 0.030 |
Why?
|
Carbamates | 1 | 2017 | 191 | 0.030 |
Why?
|
Cyclopropanes | 1 | 2017 | 436 | 0.030 |
Why?
|
Estrogen Receptor alpha | 1 | 2020 | 580 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2024 | 15403 | 0.030 |
Why?
|
Valine | 1 | 2017 | 410 | 0.030 |
Why?
|
Proline | 1 | 2017 | 453 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6506 | 0.030 |
Why?
|
Lactams, Macrocyclic | 1 | 2017 | 318 | 0.030 |
Why?
|
Glutamates | 1 | 2017 | 384 | 0.030 |
Why?
|
Ritonavir | 1 | 2017 | 331 | 0.030 |
Why?
|
Pancreas | 1 | 2022 | 1699 | 0.030 |
Why?
|
Hysterectomy | 1 | 2020 | 864 | 0.030 |
Why?
|
Anilides | 1 | 2017 | 413 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2020 | 787 | 0.030 |
Why?
|
Interferons | 1 | 2018 | 714 | 0.030 |
Why?
|
CD4 Lymphocyte Count | 1 | 2020 | 2586 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2012 | 20137 | 0.030 |
Why?
|
Spine | 1 | 2021 | 1132 | 0.030 |
Why?
|
HIV Infections | 1 | 2020 | 17535 | 0.030 |
Why?
|
Fruit | 1 | 2019 | 1167 | 0.030 |
Why?
|
Animals | 4 | 2021 | 168800 | 0.030 |
Why?
|
Age Factors | 2 | 2020 | 18386 | 0.030 |
Why?
|
Eating | 1 | 2020 | 1538 | 0.030 |
Why?
|
Evidence-Based Medicine | 1 | 2025 | 3690 | 0.030 |
Why?
|
Cesarean Section | 1 | 2021 | 1418 | 0.030 |
Why?
|
Lymphoma | 1 | 2022 | 1896 | 0.030 |
Why?
|
Societies, Medical | 1 | 2025 | 3955 | 0.030 |
Why?
|
Lipoproteins, LDL | 1 | 2015 | 642 | 0.030 |
Why?
|
Multifactorial Inheritance | 1 | 2020 | 1426 | 0.020 |
Why?
|
Diet, Mediterranean | 1 | 2019 | 746 | 0.020 |
Why?
|
Menopause | 1 | 2020 | 1659 | 0.020 |
Why?
|
Bariatric Surgery | 1 | 2022 | 997 | 0.020 |
Why?
|
Genetic Loci | 1 | 2021 | 2630 | 0.020 |
Why?
|
Hospitalization | 2 | 2021 | 10811 | 0.020 |
Why?
|
Lipoproteins | 1 | 2015 | 870 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2021 | 2116 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2021 | 2969 | 0.020 |
Why?
|
Trauma Centers | 1 | 2016 | 950 | 0.020 |
Why?
|
Brain | 1 | 2017 | 27177 | 0.020 |
Why?
|
Pregnancy | 2 | 2021 | 30233 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2015 | 1813 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2021 | 3315 | 0.020 |
Why?
|
Gastric Bypass | 1 | 2017 | 820 | 0.020 |
Why?
|
Bone Density | 1 | 2021 | 3491 | 0.020 |
Why?
|
Triglycerides | 1 | 2015 | 2441 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2020 | 4408 | 0.020 |
Why?
|
Sulfonamides | 1 | 2017 | 1980 | 0.020 |
Why?
|
Models, Statistical | 1 | 2021 | 5089 | 0.020 |
Why?
|
Cholesterol | 1 | 2015 | 2902 | 0.020 |
Why?
|
Viral Load | 1 | 2015 | 3386 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8612 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9335 | 0.010 |
Why?
|
Critical Illness | 1 | 2016 | 2749 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16716 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 2022 | 5836 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2016 | 3798 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2016 | 5340 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2021 | 26381 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 13468 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2020 | 12803 | 0.010 |
Why?
|
Veterans | 1 | 2015 | 2667 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2021 | 11509 | 0.010 |
Why?
|
Databases, Factual | 1 | 2015 | 8062 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 42511 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20700 | 0.010 |
Why?
|